Arvinas (ARVN) Other financing activities (2019 - 2023)

Arvinas (ARVN) recorded quarterly Other financing activities of $15.9 million in Q4 2023, down 40.63% quarter-over-quarter from $26.8 million in Q4 2020.

Arvinas (ARVN) Other financing activities (2019 - 2023) Analysis & Trends

Arvinas' Other financing activities history runs 3 years deep, the most recent figure standing at $15.9 million for Q4 2023.

  • In Q4 2023, Other financing activities changed N/A year-over-year to $15.9 million; the TTM figure through Dec 2024 stood at $15.9 million (down 62.75% YoY), while the FY2023 annual figure was $17.0 million, changed N/A from the prior year.
  • Other financing activities was $15.9 million for Q4 2023 at Arvinas, down from $26.8 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $26.8 million in Q4 2020 to a low of $600000.0 in Q4 2019.
  • Historically, Other financing activities has averaged $14.4 million across 3 years, with a median of $15.9 million in 2023.
  • Biggest YoY gain for Other financing activities was 4363.88% in 2020; the steepest drop was 4363.88% in 2020.
  • A 3-year view of Other financing activities shows it stood at $600000.0 in 2019, then jumped by 4363.88% to $26.8 million in 2020, then slumped by 40.63% to $15.9 million in 2023.
  • The last three Other financing activities figures came in at $15.9 million (Q4 2023), $26.8 million (Q4 2020), and $600000.0 (Q4 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arvinas 492.16 Mn -122.74 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 15.90 Mn
Dec 31, 2023 15.90 Mn
Dec 31, 2020 26.78 Mn
Dec 31, 2020 26.78 Mn
Dec 31, 2019 600,000.00
Dec 31, 2019 600,000.00